Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-04-10

AUTHORS

Fiona M. Behan, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M. Beaver, Giorgia Migliardi, Rita Santos, Yanhua Rao, Francesco Sassi, Marika Pinnelli, Rizwan Ansari, Sarah Harper, David Adam Jackson, Rebecca McRae, Rachel Pooley, Piers Wilkinson, Dieudonne van der Meer, David Dow, Carolyn Buser-Doepner, Andrea Bertotti, Livio Trusolino, Euan A. Stronach, Julio Saez-Rodriguez, Kosuke Yusa, Mathew J. Garnett

ABSTRACT

Functional genomics approaches can overcome limitations—such as the lack of identification of robust targets and poor clinical efficacy—that hamper cancer drug development. Here we performed genome-scale CRISPR–Cas9 screens in 324 human cancer cell lines from 30 cancer types and developed a data-driven framework to prioritize candidates for cancer therapeutics. We integrated cell fitness effects with genomic biomarkers and target tractability for drug development to systematically prioritize new targets in defined tissues and genotypes. We verified one of our most promising dependencies, the Werner syndrome ATP-dependent helicase, as a synthetic lethal target in tumours from multiple cancer types with microsatellite instability. Our analysis provides a resource of cancer dependencies, generates a framework to prioritize cancer drug targets and suggests specific new targets. The principles described in this study can inform the initial stages of drug development by contributing to a new, diverse and more effective portfolio of cancer drug targets. More... »

PAGES

511-516

References to SciGraph publications

  • 2010-10-27. Differential expression analysis for sequence count data in GENOME BIOLOGY
  • 2014-02-03. voom: precision weights unlock linear model analysis tools for RNA-seq read counts in GENOME BIOLOGY
  • 2017-07-05. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway in NATURE
  • 2014-01-09. Clinical development success rates for investigational drugs in NATURE BIOTECHNOLOGY
  • 2001-01. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination in NATURE GENETICS
  • 2012-11-02. LAS: A Software Platform to Support Oncological Data Management in JOURNAL OF MEDICAL SYSTEMS
  • 2018-04-30. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich in SCIENTIFIC REPORTS
  • 2014-12-05. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens in GENOME BIOLOGY
  • 2006-04-23. WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2018-08-13. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting in BMC GENOMICS
  • 2016-04-16. BAGEL: a computational framework for identifying essential genes from pooled library screens in BMC BIOINFORMATICS
  • 2013-05-29. The Genotype-Tissue Expression (GTEx) project in NATURE GENETICS
  • 2017-10-30. Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells in NATURE GENETICS
  • 2017-06-06. A molecular portrait of microsatellite instability across multiple cancers in NATURE COMMUNICATIONS
  • 2017-05-08. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients in NATURE MEDICINE
  • 2013-12-23. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library in NATURE BIOTECHNOLOGY
  • 2009-08-06. RecQ helicases: multifunctional genome caretakers in NATURE REVIEWS CANCER
  • 2019-04-10. WRN Helicase is a Synthetic Lethal Target in Microsatellite Unstable Cancers in NATURE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41586-019-1103-9

    DOI

    http://dx.doi.org/10.1038/s41586-019-1103-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1113356021

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30971826


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "CRISPR-Cas Systems", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Discovery", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Editing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genome, Human", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Microsatellite Instability", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Targeted Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Organ Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reproducibility of Results", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Synthetic Lethal Mutations", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Werner Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Werner Syndrome Helicase", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Open Targets, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK", 
                "Open Targets, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Behan", 
            "givenName": "Fiona M.", 
            "id": "sg:person.012764132277.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012764132277.88"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.225360.0", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK", 
                "Open Targets, Cambridge, UK", 
                "European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Iorio", 
            "givenName": "Francesco", 
            "id": "sg:person.01076244050.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076244050.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Picco", 
            "givenName": "Gabriele", 
            "id": "sg:person.0677514417.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677514417.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gon\u00e7alves", 
            "givenName": "Emanuel", 
            "id": "sg:person.01202450100.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202450100.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Beaver", 
            "givenName": "Charlotte M.", 
            "id": "sg:person.010542670514.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010542670514.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, University of Torino, Turin, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7605.4", 
              "name": [
                "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy", 
                "Department of Oncology, University of Torino, Turin, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Migliardi", 
            "givenName": "Giorgia", 
            "id": "sg:person.01056321421.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056321421.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline Research and Development, Stevenage, UK", 
              "id": "http://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "GlaxoSmithKline Research and Development, Stevenage, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Santos", 
            "givenName": "Rita", 
            "id": "sg:person.012521756710.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012521756710.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline Research and Development, Collegeville, PA, USA", 
              "id": "http://www.grid.ac/institutes/grid.419047.f", 
              "name": [
                "GlaxoSmithKline Research and Development, Collegeville, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rao", 
            "givenName": "Yanhua", 
            "id": "sg:person.015611577360.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015611577360.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy", 
              "id": "http://www.grid.ac/institutes/grid.419555.9", 
              "name": [
                "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sassi", 
            "givenName": "Francesco", 
            "id": "sg:person.0576262716.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576262716.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, University of Torino, Turin, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7605.4", 
              "name": [
                "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy", 
                "Department of Oncology, University of Torino, Turin, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pinnelli", 
            "givenName": "Marika", 
            "id": "sg:person.011703245330.67", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011703245330.67"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ansari", 
            "givenName": "Rizwan", 
            "id": "sg:person.0653057141.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653057141.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Harper", 
            "givenName": "Sarah", 
            "id": "sg:person.013047440514.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013047440514.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jackson", 
            "givenName": "David Adam", 
            "id": "sg:person.015544057276.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015544057276.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McRae", 
            "givenName": "Rebecca", 
            "id": "sg:person.015471131453.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015471131453.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pooley", 
            "givenName": "Rachel", 
            "id": "sg:person.011406364314.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011406364314.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilkinson", 
            "givenName": "Piers", 
            "id": "sg:person.016564607714.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016564607714.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Wellcome Sanger Institute, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.10306.34", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "van der Meer", 
            "givenName": "Dieudonne", 
            "id": "sg:person.01233123721.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233123721.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline Research and Development, Stevenage, UK", 
              "id": "http://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "Open Targets, Cambridge, UK", 
                "GlaxoSmithKline Research and Development, Stevenage, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dow", 
            "givenName": "David", 
            "id": "sg:person.01224601067.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224601067.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline Research and Development, Collegeville, PA, USA", 
              "id": "http://www.grid.ac/institutes/grid.419047.f", 
              "name": [
                "Open Targets, Cambridge, UK", 
                "GlaxoSmithKline Research and Development, Collegeville, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Buser-Doepner", 
            "givenName": "Carolyn", 
            "id": "sg:person.01135276770.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135276770.57"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, University of Torino, Turin, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7605.4", 
              "name": [
                "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy", 
                "Department of Oncology, University of Torino, Turin, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bertotti", 
            "givenName": "Andrea", 
            "id": "sg:person.01274134276.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274134276.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, University of Torino, Turin, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7605.4", 
              "name": [
                "Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy", 
                "Department of Oncology, University of Torino, Turin, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Trusolino", 
            "givenName": "Livio", 
            "id": "sg:person.0772247030.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772247030.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline Research and Development, Stevenage, UK", 
              "id": "http://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "Open Targets, Cambridge, UK", 
                "GlaxoSmithKline Research and Development, Stevenage, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stronach", 
            "givenName": "Euan A.", 
            "id": "sg:person.0737065770.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737065770.37"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heidelberg University Hospital, Heidelberg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.5253.1", 
              "name": [
                "Open Targets, Cambridge, UK", 
                "European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK", 
                "Faculty of Medicine, Joint Research Centre for Computational Biomedicine, RWTH Aachen University, Aachen, Germany", 
                "Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Bioquant, Heidelberg, Germany", 
                "Heidelberg University Hospital, Heidelberg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Saez-Rodriguez", 
            "givenName": "Julio", 
            "id": "sg:person.01307552567.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307552567.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK", 
                "Open Targets, Cambridge, UK", 
                "Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yusa", 
            "givenName": "Kosuke", 
            "id": "sg:person.0730527416.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730527416.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Open Targets, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Wellcome Sanger Institute, Cambridge, UK", 
                "Open Targets, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garnett", 
            "givenName": "Mathew J.", 
            "id": "sg:person.0644610357.89", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644610357.89"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10916-012-9891-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009324561", 
              "https://doi.org/10.1007/s10916-012-9891-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/gb-2010-11-10-r106", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031289083", 
              "https://doi.org/10.1186/gb-2010-11-10-r106"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms15180", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085883879", 
              "https://doi.org/10.1038/ncomms15180"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/83673", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011161232", 
              "https://doi.org/10.1038/83673"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature23007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1090352564", 
              "https://doi.org/10.1038/nature23007"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nsmb1088", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007138952", 
              "https://doi.org/10.1038/nsmb1088"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12859-016-1015-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013321403", 
              "https://doi.org/10.1186/s12859-016-1015-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/gb-2014-15-2-r29", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045312009", 
              "https://doi.org/10.1186/gb-2014-15-2-r29"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12864-018-4989-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106141175", 
              "https://doi.org/10.1186/s12864-018-4989-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13059-014-0554-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014314357", 
              "https://doi.org/10.1186/s13059-014-0554-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.3984", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092440098", 
              "https://doi.org/10.1038/ng.3984"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2800", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041802825", 
              "https://doi.org/10.1038/nbt.2800"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2682", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020766857", 
              "https://doi.org/10.1038/nrc2682"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-019-1102-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1113356018", 
              "https://doi.org/10.1038/s41586-019-1102-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2786", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013732820", 
              "https://doi.org/10.1038/nbt.2786"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.2653", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032444369", 
              "https://doi.org/10.1038/ng.2653"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.4333", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085214027", 
              "https://doi.org/10.1038/nm.4333"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41598-018-25076-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103690616", 
              "https://doi.org/10.1038/s41598-018-25076-6"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-04-10", 
        "datePublishedReg": "2019-04-10", 
        "description": "Functional genomics approaches can overcome limitations\u2014such as the lack of identification of robust targets and poor clinical efficacy\u2014that hamper cancer drug development. Here we performed genome-scale CRISPR\u2013Cas9 screens in 324\u00a0human cancer cell lines from 30\u00a0cancer types and developed a data-driven framework to prioritize candidates for cancer therapeutics. We integrated cell fitness effects with genomic biomarkers and target tractability for drug development to systematically prioritize new targets in defined tissues and genotypes. We verified one of our most promising dependencies, the Werner syndrome ATP-dependent helicase, as a synthetic lethal target in tumours from multiple cancer types with microsatellite instability. Our analysis provides a resource of cancer dependencies, generates a framework to prioritize cancer drug targets and suggests specific new targets. The principles described in this study can inform the initial stages of drug development by contributing to a new, diverse and more effective portfolio of cancer drug targets.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41586-019-1103-9", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.3636122", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6814298", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7753", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "568"
          }
        ], 
        "keywords": [
          "cancer drug target", 
          "drug targets", 
          "functional genomics approach", 
          "ATP-dependent helicase", 
          "genome-scale CRISPR", 
          "specific new targets", 
          "synthetic lethal target", 
          "cancer therapeutic target", 
          "new targets", 
          "fitness effects", 
          "genomic approaches", 
          "drug development", 
          "cancer dependencies", 
          "cancer types", 
          "multiple cancer types", 
          "cancer drug development", 
          "lethal target", 
          "cancer cell lines", 
          "human cancer cell lines", 
          "cancer therapeutics", 
          "cell lines", 
          "CRISPR", 
          "genomic biomarkers", 
          "therapeutic target", 
          "robust target", 
          "target", 
          "helicase", 
          "screen", 
          "microsatellite instability", 
          "poor clinical efficacy", 
          "genotypes", 
          "therapeutics", 
          "development", 
          "clinical efficacy", 
          "identification", 
          "tissue", 
          "lines", 
          "lack of identification", 
          "types", 
          "initial stage", 
          "stage", 
          "biomarkers", 
          "tractability", 
          "prioritization", 
          "candidates", 
          "tumors", 
          "analysis", 
          "effective portfolio", 
          "efficacy", 
          "lack", 
          "resources", 
          "effect", 
          "study", 
          "instability", 
          "approach", 
          "dependency", 
          "principles", 
          "framework", 
          "data-driven framework", 
          "portfolio", 
          "hamper cancer drug development", 
          "cell fitness effects", 
          "promising dependencies", 
          "Werner syndrome ATP-dependent helicase", 
          "syndrome ATP-dependent helicase", 
          "more effective portfolio"
        ], 
        "name": "Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens", 
        "pagination": "511-516", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1113356021"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41586-019-1103-9"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30971826"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41586-019-1103-9", 
          "https://app.dimensions.ai/details/publication/pub.1113356021"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_805.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41586-019-1103-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41586-019-1103-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41586-019-1103-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41586-019-1103-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41586-019-1103-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    484 TRIPLES      22 PREDICATES      129 URIs      103 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41586-019-1103-9 schema:about N0d64399be21d4e7ba35e5d0cda62ed91
    2 N20b809bc98f64c81ab655c09552f0a27
    3 N3be214f484394cbe9ccdbb8a839856c1
    4 N3c2496207ccb4084adc42a8e096cc687
    5 N3e6a5ce3eb6f4c7da231997cf32ae152
    6 N4633fb4a884945c698750b36705b3df0
    7 N4d39fadbd5a7421c8c1214263d239cd5
    8 N5e4e95d50abf4fa58d573e2cc6da19ea
    9 N771d546abae7441aadb14929551f8080
    10 N84050811bfb7491e8546db3c78ea5235
    11 N921feaca3e67421ab07ed7ae28deb198
    12 Na512d340177a4b0ba10873100014da20
    13 Nc16998f6412b4f33a833094d44769f4e
    14 Nc5cd266f9fc84a7e9b73321eab17f9e1
    15 Nd32517e528e444ba9fc6477712cede98
    16 Nd48465aecdba4be1bee2c5add38dd45e
    17 Nd5aacc206b7749eab2415e4b9a645298
    18 Nf59764e9008a49cd92acc613a3228ed2
    19 Nfa27b92b8611400d9a0b4d4eb71bf806
    20 anzsrc-for:11
    21 anzsrc-for:1112
    22 schema:author Na049ab30a3cb48b597dbaf04bbff750e
    23 schema:citation sg:pub.10.1007/s10916-012-9891-6
    24 sg:pub.10.1038/83673
    25 sg:pub.10.1038/nature23007
    26 sg:pub.10.1038/nbt.2786
    27 sg:pub.10.1038/nbt.2800
    28 sg:pub.10.1038/ncomms15180
    29 sg:pub.10.1038/ng.2653
    30 sg:pub.10.1038/ng.3984
    31 sg:pub.10.1038/nm.4333
    32 sg:pub.10.1038/nrc2682
    33 sg:pub.10.1038/nsmb1088
    34 sg:pub.10.1038/s41586-019-1102-x
    35 sg:pub.10.1038/s41598-018-25076-6
    36 sg:pub.10.1186/gb-2010-11-10-r106
    37 sg:pub.10.1186/gb-2014-15-2-r29
    38 sg:pub.10.1186/s12859-016-1015-8
    39 sg:pub.10.1186/s12864-018-4989-y
    40 sg:pub.10.1186/s13059-014-0554-4
    41 schema:datePublished 2019-04-10
    42 schema:datePublishedReg 2019-04-10
    43 schema:description Functional genomics approaches can overcome limitations—such as the lack of identification of robust targets and poor clinical efficacy—that hamper cancer drug development. Here we performed genome-scale CRISPR–Cas9 screens in 324 human cancer cell lines from 30 cancer types and developed a data-driven framework to prioritize candidates for cancer therapeutics. We integrated cell fitness effects with genomic biomarkers and target tractability for drug development to systematically prioritize new targets in defined tissues and genotypes. We verified one of our most promising dependencies, the Werner syndrome ATP-dependent helicase, as a synthetic lethal target in tumours from multiple cancer types with microsatellite instability. Our analysis provides a resource of cancer dependencies, generates a framework to prioritize cancer drug targets and suggests specific new targets. The principles described in this study can inform the initial stages of drug development by contributing to a new, diverse and more effective portfolio of cancer drug targets.
    44 schema:genre article
    45 schema:inLanguage en
    46 schema:isAccessibleForFree true
    47 schema:isPartOf N71e3ba30c8fb4849bcecd90c553c20ee
    48 N9e50d0e00f6342838b693b20d118d40e
    49 sg:journal.1018957
    50 schema:keywords ATP-dependent helicase
    51 CRISPR
    52 Werner syndrome ATP-dependent helicase
    53 analysis
    54 approach
    55 biomarkers
    56 cancer cell lines
    57 cancer dependencies
    58 cancer drug development
    59 cancer drug target
    60 cancer therapeutic target
    61 cancer therapeutics
    62 cancer types
    63 candidates
    64 cell fitness effects
    65 cell lines
    66 clinical efficacy
    67 data-driven framework
    68 dependency
    69 development
    70 drug development
    71 drug targets
    72 effect
    73 effective portfolio
    74 efficacy
    75 fitness effects
    76 framework
    77 functional genomics approach
    78 genome-scale CRISPR
    79 genomic approaches
    80 genomic biomarkers
    81 genotypes
    82 hamper cancer drug development
    83 helicase
    84 human cancer cell lines
    85 identification
    86 initial stage
    87 instability
    88 lack
    89 lack of identification
    90 lethal target
    91 lines
    92 microsatellite instability
    93 more effective portfolio
    94 multiple cancer types
    95 new targets
    96 poor clinical efficacy
    97 portfolio
    98 principles
    99 prioritization
    100 promising dependencies
    101 resources
    102 robust target
    103 screen
    104 specific new targets
    105 stage
    106 study
    107 syndrome ATP-dependent helicase
    108 synthetic lethal target
    109 target
    110 therapeutic target
    111 therapeutics
    112 tissue
    113 tractability
    114 tumors
    115 types
    116 schema:name Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
    117 schema:pagination 511-516
    118 schema:productId N941c77cbf1854f62a552d1f519520218
    119 Nc6c4931573ed449bbf14659be56e96be
    120 Ne55ec2afd82344f0abd8aac8865e9f5f
    121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113356021
    122 https://doi.org/10.1038/s41586-019-1103-9
    123 schema:sdDatePublished 2021-12-01T19:45
    124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    125 schema:sdPublisher N59d7259962444ee9b43c6cd10ba34371
    126 schema:url https://doi.org/10.1038/s41586-019-1103-9
    127 sgo:license sg:explorer/license/
    128 sgo:sdDataset articles
    129 rdf:type schema:ScholarlyArticle
    130 N0183f139803542408d64e2174a49e608 rdf:first sg:person.013047440514.99
    131 rdf:rest N0f86b7eeb33a4bc9bc1fe1d89933c7f8
    132 N0d64399be21d4e7ba35e5d0cda62ed91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Drug Discovery
    134 rdf:type schema:DefinedTerm
    135 N0f86b7eeb33a4bc9bc1fe1d89933c7f8 rdf:first sg:person.015544057276.42
    136 rdf:rest Nadafe65bffea4a1eafdf8300ccb2a419
    137 N100a6ebb17d74f67a6e8d258e93cfd63 rdf:first sg:person.0644610357.89
    138 rdf:rest rdf:nil
    139 N15d06979895f4f87bf041bdd6530688a rdf:first sg:person.016564607714.44
    140 rdf:rest Nc0537446b2a34a478601db26d42b0a3c
    141 N16314559291a4f9cbb94b3df0c595f00 rdf:first sg:person.01202450100.32
    142 rdf:rest N3dd685aace034446aa37e9a567ef9ba0
    143 N1f1985ba38be44258da39bfb9a333591 rdf:first sg:person.012521756710.30
    144 rdf:rest Nbee3247b573f4fcaba6925290663aa43
    145 N20b809bc98f64c81ab655c09552f0a27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Microsatellite Instability
    147 rdf:type schema:DefinedTerm
    148 N25470400b88643c4b7322a00e721ec08 rdf:first sg:person.0772247030.82
    149 rdf:rest Nbda728ec9b7e4239a7b178bfc36690d8
    150 N3b4dab236177430ab8316508c76e98f0 rdf:first sg:person.0730527416.11
    151 rdf:rest N100a6ebb17d74f67a6e8d258e93cfd63
    152 N3be214f484394cbe9ccdbb8a839856c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Animals
    154 rdf:type schema:DefinedTerm
    155 N3c2496207ccb4084adc42a8e096cc687 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Synthetic Lethal Mutations
    157 rdf:type schema:DefinedTerm
    158 N3dd685aace034446aa37e9a567ef9ba0 rdf:first sg:person.010542670514.05
    159 rdf:rest Ne33740ff2df949f59b21e6e16e32bebf
    160 N3e6a5ce3eb6f4c7da231997cf32ae152 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Cell Line, Tumor
    162 rdf:type schema:DefinedTerm
    163 N4633fb4a884945c698750b36705b3df0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Gene Editing
    165 rdf:type schema:DefinedTerm
    166 N4d39fadbd5a7421c8c1214263d239cd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Biomarkers, Tumor
    168 rdf:type schema:DefinedTerm
    169 N59d7259962444ee9b43c6cd10ba34371 schema:name Springer Nature - SN SciGraph project
    170 rdf:type schema:Organization
    171 N5bd1b87eaf0f4c4a928bd699c7f78765 rdf:first sg:person.01307552567.91
    172 rdf:rest N3b4dab236177430ab8316508c76e98f0
    173 N5e4e95d50abf4fa58d573e2cc6da19ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Reproducibility of Results
    175 rdf:type schema:DefinedTerm
    176 N66c31b4699314c698d0ba5831c212f77 rdf:first sg:person.0677514417.05
    177 rdf:rest N16314559291a4f9cbb94b3df0c595f00
    178 N715a54a7560440a59a1560532373d873 rdf:first sg:person.0576262716.49
    179 rdf:rest N8e94061d171342e480ee6cb86c36f38a
    180 N71e3ba30c8fb4849bcecd90c553c20ee schema:volumeNumber 568
    181 rdf:type schema:PublicationVolume
    182 N771d546abae7441aadb14929551f8080 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Mice
    184 rdf:type schema:DefinedTerm
    185 N7e9fc5e249d64b89bfd2f590c444edef rdf:first sg:person.011406364314.69
    186 rdf:rest N15d06979895f4f87bf041bdd6530688a
    187 N84050811bfb7491e8546db3c78ea5235 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Werner Syndrome
    189 rdf:type schema:DefinedTerm
    190 N8bebe349055140b283b450c46eb5501b rdf:first sg:person.01076244050.66
    191 rdf:rest N66c31b4699314c698d0ba5831c212f77
    192 N8e94061d171342e480ee6cb86c36f38a rdf:first sg:person.011703245330.67
    193 rdf:rest Nf88a86209dbb4872b33dab9ad79cfb67
    194 N921feaca3e67421ab07ed7ae28deb198 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Werner Syndrome Helicase
    196 rdf:type schema:DefinedTerm
    197 N941c77cbf1854f62a552d1f519520218 schema:name dimensions_id
    198 schema:value pub.1113356021
    199 rdf:type schema:PropertyValue
    200 N9e50d0e00f6342838b693b20d118d40e schema:issueNumber 7753
    201 rdf:type schema:PublicationIssue
    202 Na049ab30a3cb48b597dbaf04bbff750e rdf:first sg:person.012764132277.88
    203 rdf:rest N8bebe349055140b283b450c46eb5501b
    204 Na512d340177a4b0ba10873100014da20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Neoplasm Transplantation
    206 rdf:type schema:DefinedTerm
    207 Nadafe65bffea4a1eafdf8300ccb2a419 rdf:first sg:person.015471131453.12
    208 rdf:rest N7e9fc5e249d64b89bfd2f590c444edef
    209 Nb3c25592a8bc41b8b970513df1373332 rdf:first sg:person.01224601067.64
    210 rdf:rest Ne9430edbd1f84cf796f815fe3b158d04
    211 Nbda728ec9b7e4239a7b178bfc36690d8 rdf:first sg:person.0737065770.37
    212 rdf:rest N5bd1b87eaf0f4c4a928bd699c7f78765
    213 Nbee3247b573f4fcaba6925290663aa43 rdf:first sg:person.015611577360.17
    214 rdf:rest N715a54a7560440a59a1560532373d873
    215 Nc0537446b2a34a478601db26d42b0a3c rdf:first sg:person.01233123721.13
    216 rdf:rest Nb3c25592a8bc41b8b970513df1373332
    217 Nc16998f6412b4f33a833094d44769f4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name CRISPR-Cas Systems
    219 rdf:type schema:DefinedTerm
    220 Nc5cd266f9fc84a7e9b73321eab17f9e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Molecular Targeted Therapy
    222 rdf:type schema:DefinedTerm
    223 Nc6c4931573ed449bbf14659be56e96be schema:name pubmed_id
    224 schema:value 30971826
    225 rdf:type schema:PropertyValue
    226 Nd32517e528e444ba9fc6477712cede98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    227 schema:name Humans
    228 rdf:type schema:DefinedTerm
    229 Nd48465aecdba4be1bee2c5add38dd45e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    230 schema:name Neoplasms
    231 rdf:type schema:DefinedTerm
    232 Nd5aacc206b7749eab2415e4b9a645298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    233 schema:name Genome, Human
    234 rdf:type schema:DefinedTerm
    235 Ne33740ff2df949f59b21e6e16e32bebf rdf:first sg:person.01056321421.60
    236 rdf:rest N1f1985ba38be44258da39bfb9a333591
    237 Ne4c8d94270744f5f921bf6a2171a3281 rdf:first sg:person.01274134276.83
    238 rdf:rest N25470400b88643c4b7322a00e721ec08
    239 Ne55ec2afd82344f0abd8aac8865e9f5f schema:name doi
    240 schema:value 10.1038/s41586-019-1103-9
    241 rdf:type schema:PropertyValue
    242 Ne9430edbd1f84cf796f815fe3b158d04 rdf:first sg:person.01135276770.57
    243 rdf:rest Ne4c8d94270744f5f921bf6a2171a3281
    244 Nf59764e9008a49cd92acc613a3228ed2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    245 schema:name Female
    246 rdf:type schema:DefinedTerm
    247 Nf88a86209dbb4872b33dab9ad79cfb67 rdf:first sg:person.0653057141.09
    248 rdf:rest N0183f139803542408d64e2174a49e608
    249 Nfa27b92b8611400d9a0b4d4eb71bf806 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    250 schema:name Organ Specificity
    251 rdf:type schema:DefinedTerm
    252 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    253 schema:name Medical and Health Sciences
    254 rdf:type schema:DefinedTerm
    255 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    256 schema:name Oncology and Carcinogenesis
    257 rdf:type schema:DefinedTerm
    258 sg:grant.3636122 http://pending.schema.org/fundedItem sg:pub.10.1038/s41586-019-1103-9
    259 rdf:type schema:MonetaryGrant
    260 sg:grant.6814298 http://pending.schema.org/fundedItem sg:pub.10.1038/s41586-019-1103-9
    261 rdf:type schema:MonetaryGrant
    262 sg:journal.1018957 schema:issn 0028-0836
    263 1476-4687
    264 schema:name Nature
    265 schema:publisher Springer Nature
    266 rdf:type schema:Periodical
    267 sg:person.010542670514.05 schema:affiliation grid-institutes:grid.10306.34
    268 schema:familyName Beaver
    269 schema:givenName Charlotte M.
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010542670514.05
    271 rdf:type schema:Person
    272 sg:person.01056321421.60 schema:affiliation grid-institutes:grid.7605.4
    273 schema:familyName Migliardi
    274 schema:givenName Giorgia
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056321421.60
    276 rdf:type schema:Person
    277 sg:person.01076244050.66 schema:affiliation grid-institutes:grid.225360.0
    278 schema:familyName Iorio
    279 schema:givenName Francesco
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076244050.66
    281 rdf:type schema:Person
    282 sg:person.01135276770.57 schema:affiliation grid-institutes:grid.419047.f
    283 schema:familyName Buser-Doepner
    284 schema:givenName Carolyn
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135276770.57
    286 rdf:type schema:Person
    287 sg:person.011406364314.69 schema:affiliation grid-institutes:grid.10306.34
    288 schema:familyName Pooley
    289 schema:givenName Rachel
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011406364314.69
    291 rdf:type schema:Person
    292 sg:person.011703245330.67 schema:affiliation grid-institutes:grid.7605.4
    293 schema:familyName Pinnelli
    294 schema:givenName Marika
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011703245330.67
    296 rdf:type schema:Person
    297 sg:person.01202450100.32 schema:affiliation grid-institutes:grid.10306.34
    298 schema:familyName Gonçalves
    299 schema:givenName Emanuel
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202450100.32
    301 rdf:type schema:Person
    302 sg:person.01224601067.64 schema:affiliation grid-institutes:grid.418236.a
    303 schema:familyName Dow
    304 schema:givenName David
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224601067.64
    306 rdf:type schema:Person
    307 sg:person.01233123721.13 schema:affiliation grid-institutes:grid.10306.34
    308 schema:familyName van der Meer
    309 schema:givenName Dieudonne
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233123721.13
    311 rdf:type schema:Person
    312 sg:person.012521756710.30 schema:affiliation grid-institutes:grid.418236.a
    313 schema:familyName Santos
    314 schema:givenName Rita
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012521756710.30
    316 rdf:type schema:Person
    317 sg:person.01274134276.83 schema:affiliation grid-institutes:grid.7605.4
    318 schema:familyName Bertotti
    319 schema:givenName Andrea
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274134276.83
    321 rdf:type schema:Person
    322 sg:person.012764132277.88 schema:affiliation grid-institutes:None
    323 schema:familyName Behan
    324 schema:givenName Fiona M.
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012764132277.88
    326 rdf:type schema:Person
    327 sg:person.013047440514.99 schema:affiliation grid-institutes:grid.10306.34
    328 schema:familyName Harper
    329 schema:givenName Sarah
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013047440514.99
    331 rdf:type schema:Person
    332 sg:person.01307552567.91 schema:affiliation grid-institutes:grid.5253.1
    333 schema:familyName Saez-Rodriguez
    334 schema:givenName Julio
    335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307552567.91
    336 rdf:type schema:Person
    337 sg:person.015471131453.12 schema:affiliation grid-institutes:grid.10306.34
    338 schema:familyName McRae
    339 schema:givenName Rebecca
    340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015471131453.12
    341 rdf:type schema:Person
    342 sg:person.015544057276.42 schema:affiliation grid-institutes:grid.10306.34
    343 schema:familyName Jackson
    344 schema:givenName David Adam
    345 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015544057276.42
    346 rdf:type schema:Person
    347 sg:person.015611577360.17 schema:affiliation grid-institutes:grid.419047.f
    348 schema:familyName Rao
    349 schema:givenName Yanhua
    350 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015611577360.17
    351 rdf:type schema:Person
    352 sg:person.016564607714.44 schema:affiliation grid-institutes:grid.10306.34
    353 schema:familyName Wilkinson
    354 schema:givenName Piers
    355 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016564607714.44
    356 rdf:type schema:Person
    357 sg:person.0576262716.49 schema:affiliation grid-institutes:grid.419555.9
    358 schema:familyName Sassi
    359 schema:givenName Francesco
    360 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576262716.49
    361 rdf:type schema:Person
    362 sg:person.0644610357.89 schema:affiliation grid-institutes:None
    363 schema:familyName Garnett
    364 schema:givenName Mathew J.
    365 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644610357.89
    366 rdf:type schema:Person
    367 sg:person.0653057141.09 schema:affiliation grid-institutes:grid.10306.34
    368 schema:familyName Ansari
    369 schema:givenName Rizwan
    370 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653057141.09
    371 rdf:type schema:Person
    372 sg:person.0677514417.05 schema:affiliation grid-institutes:grid.10306.34
    373 schema:familyName Picco
    374 schema:givenName Gabriele
    375 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677514417.05
    376 rdf:type schema:Person
    377 sg:person.0730527416.11 schema:affiliation grid-institutes:grid.258799.8
    378 schema:familyName Yusa
    379 schema:givenName Kosuke
    380 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730527416.11
    381 rdf:type schema:Person
    382 sg:person.0737065770.37 schema:affiliation grid-institutes:grid.418236.a
    383 schema:familyName Stronach
    384 schema:givenName Euan A.
    385 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737065770.37
    386 rdf:type schema:Person
    387 sg:person.0772247030.82 schema:affiliation grid-institutes:grid.7605.4
    388 schema:familyName Trusolino
    389 schema:givenName Livio
    390 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772247030.82
    391 rdf:type schema:Person
    392 sg:pub.10.1007/s10916-012-9891-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009324561
    393 https://doi.org/10.1007/s10916-012-9891-6
    394 rdf:type schema:CreativeWork
    395 sg:pub.10.1038/83673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011161232
    396 https://doi.org/10.1038/83673
    397 rdf:type schema:CreativeWork
    398 sg:pub.10.1038/nature23007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090352564
    399 https://doi.org/10.1038/nature23007
    400 rdf:type schema:CreativeWork
    401 sg:pub.10.1038/nbt.2786 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013732820
    402 https://doi.org/10.1038/nbt.2786
    403 rdf:type schema:CreativeWork
    404 sg:pub.10.1038/nbt.2800 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041802825
    405 https://doi.org/10.1038/nbt.2800
    406 rdf:type schema:CreativeWork
    407 sg:pub.10.1038/ncomms15180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085883879
    408 https://doi.org/10.1038/ncomms15180
    409 rdf:type schema:CreativeWork
    410 sg:pub.10.1038/ng.2653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032444369
    411 https://doi.org/10.1038/ng.2653
    412 rdf:type schema:CreativeWork
    413 sg:pub.10.1038/ng.3984 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092440098
    414 https://doi.org/10.1038/ng.3984
    415 rdf:type schema:CreativeWork
    416 sg:pub.10.1038/nm.4333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085214027
    417 https://doi.org/10.1038/nm.4333
    418 rdf:type schema:CreativeWork
    419 sg:pub.10.1038/nrc2682 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020766857
    420 https://doi.org/10.1038/nrc2682
    421 rdf:type schema:CreativeWork
    422 sg:pub.10.1038/nsmb1088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007138952
    423 https://doi.org/10.1038/nsmb1088
    424 rdf:type schema:CreativeWork
    425 sg:pub.10.1038/s41586-019-1102-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1113356018
    426 https://doi.org/10.1038/s41586-019-1102-x
    427 rdf:type schema:CreativeWork
    428 sg:pub.10.1038/s41598-018-25076-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103690616
    429 https://doi.org/10.1038/s41598-018-25076-6
    430 rdf:type schema:CreativeWork
    431 sg:pub.10.1186/gb-2010-11-10-r106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031289083
    432 https://doi.org/10.1186/gb-2010-11-10-r106
    433 rdf:type schema:CreativeWork
    434 sg:pub.10.1186/gb-2014-15-2-r29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045312009
    435 https://doi.org/10.1186/gb-2014-15-2-r29
    436 rdf:type schema:CreativeWork
    437 sg:pub.10.1186/s12859-016-1015-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013321403
    438 https://doi.org/10.1186/s12859-016-1015-8
    439 rdf:type schema:CreativeWork
    440 sg:pub.10.1186/s12864-018-4989-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1106141175
    441 https://doi.org/10.1186/s12864-018-4989-y
    442 rdf:type schema:CreativeWork
    443 sg:pub.10.1186/s13059-014-0554-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014314357
    444 https://doi.org/10.1186/s13059-014-0554-4
    445 rdf:type schema:CreativeWork
    446 grid-institutes:None schema:alternateName Open Targets, Cambridge, UK
    447 schema:name Open Targets, Cambridge, UK
    448 Wellcome Sanger Institute, Cambridge, UK
    449 rdf:type schema:Organization
    450 grid-institutes:grid.10306.34 schema:alternateName Wellcome Sanger Institute, Cambridge, UK
    451 schema:name Wellcome Sanger Institute, Cambridge, UK
    452 rdf:type schema:Organization
    453 grid-institutes:grid.225360.0 schema:alternateName European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK
    454 schema:name European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK
    455 Open Targets, Cambridge, UK
    456 Wellcome Sanger Institute, Cambridge, UK
    457 rdf:type schema:Organization
    458 grid-institutes:grid.258799.8 schema:alternateName Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan
    459 schema:name Open Targets, Cambridge, UK
    460 Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan
    461 Wellcome Sanger Institute, Cambridge, UK
    462 rdf:type schema:Organization
    463 grid-institutes:grid.418236.a schema:alternateName GlaxoSmithKline Research and Development, Stevenage, UK
    464 schema:name GlaxoSmithKline Research and Development, Stevenage, UK
    465 Open Targets, Cambridge, UK
    466 rdf:type schema:Organization
    467 grid-institutes:grid.419047.f schema:alternateName GlaxoSmithKline Research and Development, Collegeville, PA, USA
    468 schema:name GlaxoSmithKline Research and Development, Collegeville, PA, USA
    469 Open Targets, Cambridge, UK
    470 rdf:type schema:Organization
    471 grid-institutes:grid.419555.9 schema:alternateName Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy
    472 schema:name Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy
    473 rdf:type schema:Organization
    474 grid-institutes:grid.5253.1 schema:alternateName Heidelberg University Hospital, Heidelberg, Germany
    475 schema:name European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK
    476 Faculty of Medicine, Joint Research Centre for Computational Biomedicine, RWTH Aachen University, Aachen, Germany
    477 Heidelberg University Hospital, Heidelberg, Germany
    478 Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Bioquant, Heidelberg, Germany
    479 Open Targets, Cambridge, UK
    480 rdf:type schema:Organization
    481 grid-institutes:grid.7605.4 schema:alternateName Department of Oncology, University of Torino, Turin, Italy
    482 schema:name Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy
    483 Department of Oncology, University of Torino, Turin, Italy
    484 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...